- Ewing TJ, Makino S, Skillman AG, Kuntz ID
(2001) DOCK 4.0: search strategies for auto-
mated molecular docking of flexible molecule
databases. J Comput Aided Mol Des
15:411–428
- Gorelik B, Goldblum A (2008) High quality
binding modes in docking ligands to proteins.
Proteins 71:1373–1386
- Morris GM, Goodsell DS, Huey R, Olson AJ
(1996) Distributed automated docking of flex-
ible ligands to proteins: parallel applications of
AutoDock 2.4. J Comput Aided Mol Des
10:293–304
- Jones G, Willett P, Glen RC, Leach AR, Taylor
R (1997) Development and validation of a
genetic algorithm for flexible docking. J Mol
Biol 267:727–748
- Santos RN, Andricopulo AD (2013) Physics
and its interfaces with medicinal chemistry
and drug design. Braz J Phys 43:268–280
- Foloppe N, Hubbard R (2006) Towards pre-
dictive ligand design with free-energy based
computational methods? Curr Med Chem
13:3583–3608
- Huang SY, Grinter SZ, Zou X (2010) Scoring
functions and their evaluation methods for pro-
tein–ligand docking: recent advances and
future directions. Phys Chem Chem Phys
12:12899–12908
- Murray C, Auton TR, Eldridge MD (1998)
Empirical scoring functions. II. The testing of
an empirical scoring function for the prediction
of ligand-receptor binding affinities and the use
of Bayesian regression to improve the quality of
the model. J Comput Aided Mol Des
12:503–519
- Huang SY, Zou X (2006) An iterative
knowledge-based scoring function to predict
protein–ligand interactions: I. Derivation of
interaction potentials. J Comput Chem
27:1866–1875
- Mysinger MM, Shoichet BK (2010) Rapid
context-dependent ligand desolvation in
molecular docking. J Chem Inf Model
50:1561–1573
- Ruvinsky AM (2007) Role of binding entropy
in the refinement of protein–ligand docking
predictions: analysis based on the use of
11 scoring functions. J Comput Chem
28:1364–1372
- Lionta E, Spyrou G, Vassilatis DK, Cournia Z
(2014) Structure-based virtual screening for
drug discovery: principles, applications and
recent advances. Curr Top Med Chem
14:1923–1938
- Scior T, Bender A, Tresadern G, Medina-
Franco JL, Martı ́nez-Mayorga K, Langer T,
Cuanalo-Contreras K, Agrafiotis DK (2012)
Recognizing pitfalls in virtual screening: a crit-
ical review. J Chem Inf Model 52:867–881
- Jain AN, Nicholls A (2008) Recommendations
for evaluation of computational methods. J
Comput Aided Mol Des 22:133–139
- Moura Barbosa AJ, Del Rio A (2012) Freely
accessible databases of commercial compounds
for high- throughput virtual screenings. Curr
Top Med Chem 12:866–877
- Rose PW, Prlic ́A, Ali A et al (2017) The RCSB
protein data bank: integrative view of protein,
gene and 3D structural information. Nucleic
Acids Res 45:D271–D281
- Valli M, dos Santos RN, Figueira LD et al
(2013) Development of a natural products
database from the biodiversity of Brazil. J Nat
Prod 76:439–444
- Williams AJ (2008) Public chemical compound
databases. Curr Opin Drug Discov Devel
11:393–404
- Nicola G, Liu T, Gilson MK (2012) Public
domain databases for medicinal chemistry. J
Med Chem 55:6987–7002
- Williams A, Tkachenko V (2014) The Royal
Society of Chemistry and the delivery of chem-
istry data repositories for the community. J
Comput Aided Mol Des 28:1023–1030
- Irwin JJ, Sterling T, Mysinger MM et al (2012)
ZINC: a free tool to discover chemistry for
biology. J Chem Inf Model 52:1757–1768
- Trott O, Olson AJ (2010) AutoDock Vina:
improving the speed and accuracy of docking
with a new scoring function, efficient optimiza-
tion and multithreading. J Comput Chem
31:455–461
- Pirhadib S, Sunseria J, Koes DR (2016) Open
source molecular modeling. J Mol Graph
Model 69:127–143
- O’Boyle NM, Banck M, James CA et al (2011)
Open babel: an open chemical toolbox. J Che-
minform 3:33
- Pettersen EF, Goddard TD, Huang CC et al
(2004) UCSF chimera: a visualization system
for exploratory research and analysis. J Comput
Chem 25:1605–1612
- Knight ZA, Gonzalez B, Feldman ME et al
(2006) A pharmacological map of the PI3-K
family defines a role for p110alpha in insulin
signaling. Cell 125:733–747
- Wu P, Liu T, Hu Y (2009) PI3K inhibitors for
cancer therapy: what has been achieved so far?
Curr Med Chem 16:916–930
- Brana I, Siu LL (2012) Clinical development of
phosphatidylinositol 3-kinase inhibitors for
cancer treatment. BMC Med 10:161
Molecular Docking and Structure-Based Virtual Screening 49
